Alpha Tau Medical Ltd. (DRTS)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

14.41 on 9 Oct 2026

0 buys1 sale at will8 planned sales

Fiscal year 2025, ended 31 Dec 2025, as filed

Net income

$42.63M

Free cash flow

$32.76M

Return on equity

-55.3%

Return on capital

-43.3%

Debt to equity

0.00

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
21 Aug 2026	Levy Raphi Chief Financial Officer	Sold on a plan	$43.07K	3.1%
11 Aug 2026	Levy Raphi Chief Financial Officer	Sold on a plan	$248.28K	16.4%
6 Jul 2026	Levy Raphi Chief Financial Officer	Sold on a plan	$31.78K	2.5%
2 Jul 2026	Levy Raphi Chief Financial Officer	Sold on a plan	$232.40K	16.5%
1 Jul 2026	Levy Raphi Chief Financial Officer	Sold on a plan	$27.69K	2.3%
30 Jun 2026	Levy Raphi Chief Financial Officer	Sold on a plan	$240.04K	18.2%

29out of 100

Profitability 0

Financial strength 60

Growth n/a

Insiders 35

Strongest on financial strength (60), weakest on profitability (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$0.00

0 buys, 0 buyers

Sold

$1.56M

9 sales

Planned sales

89%

under a 10b5-1 plan